# Canrenone as Add-on in Patients With Essential Hypertension

> **NCT02687178** · PHASE4 · COMPLETED · sponsor: **University of Pavia** · enrollment: 180 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Canrenone 50 vs canrenone 100 mg

## Key facts

- **NCT ID:** NCT02687178
- **Lead sponsor:** University of Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2015-10
- **Final completion:** 2016-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2016-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687178, "Canrenone as Add-on in Patients With Essential Hypertension". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02687178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*